| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 126,9 k € | — | — | — | ||||||||||
| Gross margin | 29,2 k € | -7.8% | 31,6 k € | -27.5% | 43,6 k € | +31.4% | 33,2 k € | -31.0% | 48,1 k € | -9.1% | 52,9 k € | +0.9% | 52,4 k € | +12.9% | 46,4 k € | -6.4% | 49,6 k € | -17.6% | 60,2 k € | |
| EBITDA | 23,2 k € | -18.5% | 28,5 k € | -30.5% | 41,0 k € | +29.2% | 31,8 k € | -31.8% | 46,6 k € | -9.2% | 51,3 k € | +0.3% | 51,1 k € | +13.4% | 45,1 k € | -6.5% | 48,2 k € | -19.0% | 59,5 k € | |
| Operating profit | 20,6 k € | -22.5% | 26,6 k € | -32.8% | 39,6 k € | +27.9% | 30,9 k € | -18.3% | 37,8 k € | -2.5% | 38,8 k € | +4.5% | 37,1 k € | +19.3% | 31,1 k € | -9.2% | 34,3 k € | -34.5% | 52,4 k € | |
| Profit/loss | 6,7 k € | -63.7% | 18,6 k € | -51.6% | 38,4 k € | +78.2% | 21,6 k € | -24.0% | 28,4 k € | -3.0% | 29,3 k € | +6.8% | 27,4 k € | +32.5% | 20,7 k € | -9.4% | 22,8 k € | -36.3% | 35,8 k € | |
| Equity | 105,6 k € | +6.8% | 98,9 k € | +23.1% | 80,3 k € | +43.0% | 56,2 k € | +14.9% | 48,9 k € | -64.1% | 136,0 k € | +27.4% | 106,7 k € | +34.5% | 79,3 k € | +35.3% | 58,7 k € | +63.7% | 35,8 k € | |
| Total assets | 335,2 k € | +183.7% | 118,1 k € | +23.9% | 95,3 k € | +27.8% | 74,6 k € | +31.0% | 57,0 k € | -61.4% | 147,7 k € | -0.3% | 148,1 k € | +23.4% | 120,0 k € | -12.1% | 136,5 k € | +82.5% | 74,8 k € | |
| Cash | 44,5 k € | -6.7% | 47,6 k € | +64.4% | 29,0 k € | -28.0% | 40,2 k € | +24.7% | 32,3 k € | -71.6% | 113,6 k € | +13.3% | 100,3 k € | +44.5% | 69,4 k € | +20.3% | 57,7 k € | +40.1% | 41,2 k € | |
| Debts | 229,5 k € | +1093.4% | 19,2 k € | +28.1% | 15,0 k € | -18.5% | 18,4 k € | +128.2% | 8,1 k € | -30.9% | 11,7 k € | -71.7% | 41,4 k € | +1.7% | 40,7 k € | -47.8% | 77,9 k € | +99.7% | 39,0 k € | |
Private limited company · Verlaine · incorporated on 19/09/2014
Private limited company profitable and well capitalised. Cash position declining (-6.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
JPHARMA is a Private limited company incorporated in 2014. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Verlaine.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette